Influenza Prevention and Treatment- PSM.pptx

sudarshankale2 65 views 38 slides Aug 02, 2024
Slide 1
Slide 1 of 38
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38

About This Presentation

PSM Topic


Slide Content

Influenza Guided By- Dr. Sudarshan Kale Associate Professor Dept. of Swasthavritta D.M.M. Ayurved College, Yavatmal

Introduction- Influenza is an acute respiaratory tract infection caused by influenza virus of which there are three types- A -Pandemic + Epidemic ( 2-3yrs) B - Epidemic (4-7 yrs.) C Family - Orthomyxoviridae

Influenza is truly an international disease, it occurs in all countries and affects millions of people every year. Its behaviour is unpredictable It may occure in pandemics every 10-15 yrs due to major antegenic changes – 1918 – Spanish influenza 1957 – Asian influenza 1968 – hongkong influenza There may be outbreaks of influenza practically every year and sometimes twice a year. The peaks of epidemic is reached in 3 – 4 weeks before tending to decline.

Why influenza spreads rapidly ? Short incubation period large number of subclinical cases high proportion of susceptible population Short duration of immunity absence of cross immunity

Influenza A & B Influenza Virus Two surface antigens: Haemagglutinin (HA) Initiates infection following attachment of virus to susceptible cells Neuraminidase (NA) Release of virus from infected cell 16 'H' antigens (1-16) 9 'N' antigens (1-9) Different combinations of H and N antigens

Influenza Virus - 3 Types Type A Type B Type C Causes significant disease: epidemics; pandemics Causes significant disease: milder epidemics Does not cause significant disease Infects both humans and other species Limited to humans Limited to humans Frequent antigenic variations Infrequent antigenic variations! Antigenically stable

Antigenic variation Influenza A – is unique among these viruses because it is frequently subject to antigenic variation both major and minor. Shift- when there is sudden complete or major change it is called as shift. Drift – when antigenic change is gradual over a period of time it is called as drift. Antigenic shift appears to result from genetic recombination of human with animal or avian viruses , providing a major antigenic change. This can cause a major epidemic or pandemic

Reservoir of Infection Influenza A – The major reservoir of influenza virus is animal and birds such as, Swine Horse Dogs cats Domestic poultry wild birds Influenza B & C- these viruses are found only in man

Influenza A(H1N1) T ransmission Through Species

  Age & Sex: All ages, both sexes Attack rates lower among adults High Case Fatality Ratio (CFR) during epidemic in high risk cases: (old people; children; persons with diabetes, heart disease, renal & resp. diseases)   Human Immunity Antibodies to 'H': neutralises the virus Antibodies to 'N': modifies the infection Antibodies appear in 7 days after an attack; reach maximum level in 2 weeks; drops to pre-infection level in 8-12 months Host Factors

Children under 18 months Old people above 18 months DM, CHD, Kidney disease Respiaratory disease. Who is at greatest risk?

Seasonality: Temperate zones : epidemics occur in winter Tropics : epidemics occur in rainy season Sporadic cases : any month   Overcrowding: Enhances transmission Higher attack rates in closed population groups (schools, institutions, ships etc.) Environmental Factors

U sually case The secretions of respiaratory tract are infective. Source of Infection

Virus is present in the nasopharynx from 1 to 2days before and 1 to 2 days after onset of symptoms. Period of Infectivity

Droplet Infection & Droplet Nuclei Mode of Transmission

The virus can be spread when a person touches something that is contaminated with the virus and then touches his or her eyes, nose, or mouth. Droplets from a cough or sneeze of an infected person move through the air. The virus can then be spread when a person touches respiratory droplets from another person on a surface like a desk, doorknob, child’s toy or phone handset and then touches their own eyes, mouth or nose before washing their hands. Fomite borne transmission is also possible

Respiaratory tract Portal of Entry

Incubation period: 18 to 72 hours Incubation period

Pathogenesis .

Fever with chills (fever last for1-5 days, average 3 days) cough Body ache Generalised weakness Diarrhoea Vomiting Nausea Throat pain (sore throat ) Clinical features

Pneumonia Respiratory failure Sinusitis Otitis media Purulent bronchitis Complication

What is swine flu? Swine Influenza (swine flu) is a respiratory disease of pigs caused by Type A influenza viruses that causes regular outbreaks in pigs. Swine flu viruses have been reported to spread from person-to-person.. This type of outbreaks are mainly found in colder season.

Present Swine flu Strains At this time , there are four main influenza type. A virus sub types that have been isolated in pigs: H1N1 , H1N2 , H3N2 , & H3N1 . However, most of the recently isolated influenza viruses from pigs have been H1N1 viruses.

Fast breathing Bluish skin colour Not drinking enough fluids Not waking up Not interacting So irritable Flu symptoms subside but fever and cough increases. Children’s emergency signs

Difficulty breathing or shortness of breath, Dyspnoea, Hypoxia Pain or pressure in the chest or abdomen Sudden dizziness Confusion ( CNS involvement ) Severe or persistent vomiting severe dehydration shock Renal failure Adult’s emergency sign

Virus isolation nasopharyngeal secretions are best specimen. Real time PCR (RT-PCR) indirect fluorescent antibody technique viral culture Lab diagnosis

Swine to Human contact- by using mask, gloves, in swine farm. Preventive measures of Influenza

Human to Human contact- 1) Good ventilation of public building avoidance of crowded places 2) Encouraging people to cover their faces with handkerchief when coughing and sneezing. .

3) Stay at home when first sign of flue seen. .

. 4) Avoid touching to eyes, nose, mouth and faces.

5) Wash hands frequently with warm water and soap. Or Alcohol based hand sanitizers.

7). Disinfect household surfaces by chlorine bleach solution. 8). Using N95 mask. .

Vaccine is not recommended in general population. In view of the changing antigenic characteristics of the virus (i.e. antigenic shift and drift ) new vaccines are constantly required, they should contain H and N component of the prevalent strain to keep the vaccine up to date. WHO makes recommendation every year as to what strain should be included in the vaccine. WHO recommends to all countries to immunise all health care worker as a first priority. Immunization

PANENZA- It is inactivated monovalent vaccine. this vaccine contains antigen equivalent to A/ california /7/2009(H1N1)V like strain dose 0.5ml IM (arm) It is stored at 2 to 8 deg.c This vaccine is effective after 14 days of vaccination. Vaccines

These vaccines are given via nasal sprays. Live attenuated vaccine

Drugs which are effective in Swine Flu There are four different antiviral drugs that are licensed for use for the treatment of influenza: Amantidine, rimantadine, oseltamivir and zanamivir . While most swine influenza viruses have been susceptible to all four drugs Drugs proved resistant at Present Most recent swine influenza viruses isolated from humans are resistant to Amantidine and Rimantadine Treatment

1) Oseltamivir (M.N. Tamiflu) Wt < 15kg – 30mg 15- 23kg -45mg 24- 40kg – 60mg >40kg – 75mg B.D. for 5 days cap-75mg syp-12mg/ml 2) Fluid management 3) Symptomatic T/t. Treatment

.